HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Epigenetic effects of trisomy 16 in the human placenta].

Abstract
The methylation profiles of the placental tissues of human embryos with normal karyotype and trisomy 16 were compared using Infinium HumanMethylation27 BeadChip array (Illumina, United States). Numerous differences between the extraembryonic tissues with diploid and aneuploid karyotypes were observed. The extraembryonic mesoderm of embryos with trisomy 16 appeared to be less methylated compared to the diploid tissue, whereas the cytotrophoblast of aneuploid embryos was hypermethylated. The presence of the supernumerary chromosome was shown to influence the epigenetic profile of the genome changing the level of methylation of CpG sites of all chromosomes. However, the biggest number of differentially methylated loci was found on the chromosome 16. Besides, more often the epimutations were tissue-specific. The hypomethylated genes in both tissues belong to the groups of genes responsible for different metabolic processes, whereas the hypermethylated genes control the processes of development, cell adhesion, immune response, and response to stimulus.
AuthorsE N Tolmacheva, A A Kashevarova, N A Skriabin, I N Lebedev
JournalMolekuliarnaia biologiia (Mol Biol (Mosk)) 2013 May-Jun Vol. 47 Issue 3 Pg. 423-32 ISSN: 0026-8984 [Print] Russia (Federation)
PMID23888773 (Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Chromosomes, Human, Pair 16 (genetics)
  • CpG Islands
  • DNA Methylation (genetics)
  • Embryo, Mammalian
  • Female
  • Humans
  • Male
  • Mesoderm
  • Mosaicism
  • Placenta
  • Pregnancy
  • Trisomy (genetics, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: